Airsculpt Technologies, Inc. (AIRS)

AirSculpt Technologies' stock has experienced significant volatility in the past six months. The company delayed filing its annual report, citing additional time needed to complete the classification of inter-company transactions and balances, and reported preliminary fiscal year 2025 revenue of $151.8 million, slightly missing market expectations. Despite these challenges, a refreshed marketing strategy led to positive comparable sales in February 2026, and the company anticipates first-quarter 2026 revenue between $38.5 million and $39.5 million. Insider confidence was highlighted by major shareholder Jorey Chernett's purchase of 105,848 shares in March 2026. The stock price saw a significant decline of 70% over the past year, but also experienced spikes following CEO remarks about 2026 momentum. On April 1, 2026, AirSculpt Technologies reported quarterly earnings of $0.03 EPS, surpassing the consensus estimate of ($0.03), though its revenue of $33.44 million missed the $34.93 million estimate. The announcement of the Q4 and FY 2025 earnings release on April 2, 2026, led to a moderate negative market reaction, with the stock declining 4.95%.

While seasonality is considered for AIRS stock performance, explicit details regarding the seasonal demand patterns for AirSculpt Technologies' products and services are not provided. The information available primarily focuses on quarterly revenue and case volume changes, such as declines in Q2 2025 and Q4 2025, and an improvement in demand trends at year-end 2025 leading to positive comparable sales in February 2026. However, these do not directly describe inherent seasonal fluctuations in customer demand for body contouring procedures.

AirSculpt Technologies, Inc. (AIRS) is a healthcare company specializing in premium body contouring procedures under the Elite Body Sculpture brand. The company offers minimally invasive fat removal and fat transfer procedures, including the AirSculpt® method, AirSculpt+, and AirSculpt Smooth. They also provide fat transfer procedures to enhance areas such as the breasts, buttocks, hips, or aging hands.

AirSculpt Technologies, Inc. operates across the United States, Canada, and the United Kingdom. As of March 2025, the company had 31 offices open throughout North America, with locations in numerous major U.S. cities and Toronto in Canada.

AirSculpt Technologies maintains a brand reputation as a premium provider of body contouring procedures, emphasizing a high-quality consumer experience. The company's focus on proprietary, minimally invasive techniques contributes to its image as an industry leader. The expansion and redesign of its Scottsdale location in March 2024, which added more space for patient care and introduced new services like AirSculpt Lift, demonstrate the company's commitment to innovation and meeting patient demand.

AirSculpt Technologies, Inc. has significant institutional and insider ownership. Major institutional owners include Vesey Street Capital Partners, L.L.C., Balyasny Asset Management Llc, and Vanguard Group Inc. Individual insider owners include Adam T. Feinstein, Aaron Rollins, Jorey Chernett, and Ronald P. Zelhof. Insiders collectively own approximately 76.58% of the stock, while institutional shareholders own about 67.62%.